Patents by Inventor Paul Lip Jin Tan

Paul Lip Jin Tan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220290184
    Abstract: The present invention relates to novel strains of pig that are highly suitable for xenotransplantation. The first novel pig strain lacks functional porcine endogenous retroviruses so is suitable as a donor for tissue and/or cell xenotransplantation into a human recipient. These pigs can also be used as a foundation pig for further manipulation, for example, by gene editing of xenoantigens to produce a second novel strain of pig that is not only free of infectious porcine retroviruses but is also free of the main xenoantigens responsible for hyperacute organ rejection. These pigs can be used for whole organ, tissue and/or cell transplantation into a human recipient.
    Type: Application
    Filed: July 31, 2020
    Publication date: September 15, 2022
    Applicant: NZENO LIMITED
    Inventors: Paul Lip Jin TAN, Olga GARKAVENKO, Robert Bartlett ELLIOTT
  • Publication number: 20090214660
    Abstract: The present invention is directed to a composition comprising high mannuronic acid-containing alginate and a polycation having a polydispersity index of less than 1.5. The composition is particularly useful for making biocompatible microcapsules containing living cells for allo- or xeno-transplantation. Such microcapsules have enhanced durability and can maintain their structural and functional integrity over long periods of time compared to prior art alginate microcapsules.
    Type: Application
    Filed: October 24, 2006
    Publication date: August 27, 2009
    Applicant: Living Cell Products Pty Limited
    Inventors: Alfred Vasconcellos, Dwaine Emerich, Chris Thanos, Briannan Bintz, Marilyn Sandra Geaney, Stephen John Martin Skinner, Paul Lip Jin Tan
  • Publication number: 20090162325
    Abstract: The present invention is directed to the prevention or treatment of autoimmune diseases, and in particular, of type I diabetes, by administering a therapeutically effective amount of an implantable composition comprising living choroid plexus cells.
    Type: Application
    Filed: June 7, 2006
    Publication date: June 25, 2009
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Paul Lip Jin Tan
  • Publication number: 20080119909
    Abstract: The present invention is directed to the prevention or treatment of sensorineural hearing loss by administering a therapeutically effective amount of an implantable composition comprising encapsulated living choroid plexus cells.
    Type: Application
    Filed: March 6, 2007
    Publication date: May 22, 2008
    Applicants: NEUROTROPHINCELL PTY LIMITED, LIVING CELL TECHNOLOGIES PTY LIMITED
    Inventors: Stephen John Martin Skinner, Marilyn Sandra Geaney, Paul Lip Jin Tan, Robert Keith Shepherd, Lisa Narelle Pettingill, Jacqueline Kate Andrew, Christopher Thanos, Dwaine Emerich